Barile M F, Chandler D K, Yoshida H, Grabowski M W, Harasawa R, Razin S
Laboratory of Mycoplasma, Food and Drug Administration, Bethesda, Maryland 20892.
Infect Immun. 1988 Sep;56(9):2443-9. doi: 10.1128/iai.56.9.2443-2449.1988.
An animal model for evaluating the potency of Mycoplasma pneumoniae vaccines was developed with hamsters. Factors that influence hamster infection by M. pneumoniae were defined, and parameters for assessment of intensity of pulmonary disease were established. Colonization of hamster lungs was determined by culture, and intensity of lung disease was assessed histopathologically and expressed numerically as a lung pathological score. Intratracheal inoculation of the challenge was superior to the intranasal or aerosol route for inducing a consistent degree of lung disease. A challenge dose of 10(6) CFU inoculated intratracheally produced lung colonization and significant reproducible lung pathological scores in essentially all unvaccinated animals. The peak of infection, as determined by these criteria, was at about 2 weeks after challenge. Animals over 6 weeks of age were preferable for the test, since younger animals exhibited a lower lung pathological score even though they showed the same degree of lung colonization. The hamster assay developed provides a dependable experimental system for testing the protective potency of M. pneumoniae vaccines.
利用仓鼠建立了一种评估肺炎支原体疫苗效力的动物模型。确定了影响仓鼠感染肺炎支原体的因素,并建立了评估肺部疾病严重程度的参数。通过培养确定仓鼠肺部的定植情况,通过组织病理学评估肺部疾病的严重程度,并以肺部病理评分的形式进行数值表达。对于诱导一致程度的肺部疾病,气管内接种攻毒株优于鼻内或气溶胶途径。气管内接种10(6) CFU的攻毒剂量在基本上所有未接种疫苗的动物中都产生了肺部定植和显著可重复的肺部病理评分。根据这些标准确定的感染高峰在攻毒后约2周。6周龄以上的动物更适合用于该试验,因为较年幼的动物尽管肺部定植程度相同,但肺部病理评分较低。所建立的仓鼠试验为测试肺炎支原体疫苗的保护效力提供了一个可靠的实验系统。